RODI OVA

RODI OVA
Product Description

RODI FERTILITY

  • Country/Region:
    Cyprus
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Start-up
Primary activities
Biopharmaceutical

RODI FERTILITY

  • Country/Region:
    Cyprus
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Start-up
Primary activities
Biopharmaceutical

More Products from RODI FERTILITY (2)

  • RODI NK™

    Product RODI NK™

    Revolutionary Approach to Pregnancy's Greatest Challenge First-in-Class, FIrst -to -Market, Patented technology RODI NK™ addresses "The Immunological Paradox of Pregnancy" - the delicate balance between immune protection and embryo tolerance during the critical first trimester. Specifically formu...

RODI FERTILITY resources (2)

  • News RODI Fertility: Revolutionizing Reproductive Medicine with Immune-Based Solutions

    RODI Fertility was created to address one of the most persistent gaps in reproductive medicine: women who experience miscarriage, implantation failure, or repeated IVF failure despite “normal” findings. Led by Dr. Barbara Geladakis, RODI pioneered an immune-based approach that reframes fertility care through the lens of reproductive immunology—bringing science, clinical insight, and compassion into one protocol-driven solution.